Rs8051542

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

Breast cancer susceptibility loci and mammographic density.

Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.

Leveraging genetic variability across populations for the identification of causal variants.

Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.

Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.